D-0502-2023 Class II Terminated

Recalled by RemedyRepack Inc. — Indiana, PA

FDA drug recall D-0502-2023 was initiated by RemedyRepack Inc. on Mar 20, 2023 and is designated Class II. Reason for recall: cGMP Deviations The recall status is terminated (terminated Oct 19, 2023). Affected quantity: a) 76 bottles, b)151 bottles.

Recall details

Product Type
Drugs
Report Date
Apr 12, 2023
Initiation Date
Mar 20, 2023
Termination Date
Oct 19, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
a) 76 bottles, b)151 bottles

Product description

Rosuvastatin 40mg tablets, packaged in a) 45-count bottles (NDC 70518-1311-01), and b) 90-count bottles (NDC 70518-0484-00), Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701.

Reason for recall

cGMP Deviations

Distribution pattern

RemedyRepack distributed product to consignees nationwide within the United States

Code information

Lot # a): B2038806-123022, B2014185-121422, B1925528-102522, Exp. Date 07/31/2025. Lot #: b): B2080829-012823, B1938007-110222, B2038746-123022, Exp. Date 07/31/2025.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0502-2023
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0502-2023. Report a data issue: hello@regdatalab.com.